This site is intended for healthcare professionals only
News
Share this article

Three-year effects of liraglutide 3 mg in obese adults with pre-diabetes

Results from a post hoc analysis of the phase 3a SCALE (Satiety and Clinical Adiposity – Liraglutide Evidence) trial show that people with obesity and prediabetes treated with liraglutide 3 mg are more likely to have consistent weight loss and improved blood glucose control over 3 years compared with those who receive placebo. The findings suggest that the glucagon-like peptide-1 receptor agonist may be an effective option for a population in whom weight loss does not typically last beyond 6 months.

In the trial, adults with prediabetes and obesity or who were overweight with comorbidities were randomised to receive liraglutide (n=1505) or placebo (n=749) for 160 weeks, both as an adjunct to a reduced-calorie diet and increased physical activity. Participants were categorised according to baseline BMI as overweight or class 1–3 obese. All four categories had consistent weight loss at 3 years compared with placebo, with mean weight loss ranging from 5.7% to 6.5% compared with 1.8% to 2.1% in placebo recipients.

The proportion of individuals who reverted to normal blood glucose levels on liraglutide was also similar across the four categories, ranging from 63% to 70%, and significantly greater compared with placebo (33–40%). In addition, improvements in a number of measures of glycaemic control were observed compared with placebo.

More details on the study can be read here.

Related content
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.